BioMarin Pharmaceuticals
BMRN
BMRN
341 hedge funds and large institutions have $13.4B invested in BioMarin Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 108 increasing their positions, 133 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
8% more funds holding
Funds holding: 316 → 341 (+25)
19% less repeat investments, than reductions
Existing positions increased: 108 | Existing positions reduced: 133
Holders
341
Holding in Top 10
11
Calls
$116M
Puts
$59M
Top Buyers
| 1 | +$130M | |
| 2 | +$121M | |
| 3 | +$113M | |
| 4 |
VAM
Visium Asset Management
New York
|
+$89.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$76.9M |
Top Sellers
| 1 | -$118M | |
| 2 | -$94.1M | |
| 3 | -$84.1M | |
| 4 |
Alkeon Capital Management
New York
|
-$59.4M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$54.3M |